Free Trial

Lexicon Pharmaceuticals (LXRX) SEC Filings & 10K Form

$1.61
-0.01 (-0.62%)
(As of 09/6/2024 ET)

Recent Lexicon Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/15/2024
11:15 PM
Lexicon Pharmaceuticals (Filer)
Form EFFECT
08/15/2024
3:47 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
7:39 AM
Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
7:40 AM
Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
8:37 AM
Lexicon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/02/2024
6:06 AM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
4:44 PM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
07/29/2024
4:31 PM
Invus Global Management, LLC (Reporting)
Lexicon Pharmaceuticals (Issuer)
Siren, L.L.C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
9:10 AM
FMR LLC (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13G
07/08/2024
4:26 PM
Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
4:27 PM
Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:27 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
8:15 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
11:15 PM
Lexicon Pharmaceuticals (Filer)
Form EFFECT
05/14/2024
4:17 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:00 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:01 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:02 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:03 PM
LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
4:14 PM
Lexicon Pharmaceuticals (Filer)
Form S-3/A
04/29/2024
3:16 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
3:17 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
3:17 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
3:18 PM
LEFKOWITZ ROBERT J MD (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
3:20 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
3:21 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
8:00 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2024
3:05 PM
Lexicon Pharmaceuticals (Filer)
Form ARS
03/26/2024
6:05 AM
Lexicon Pharmaceuticals (Filer)
Form DEF 14A
03/26/2024
6:06 AM
Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/25/2024
3:17 PM
Lexicon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/13/2024
8:20 PM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
03/13/2024
8:22 PM
Artal Group S.A. (Reporting)
Artal International Management S.A. (Reporting)
Artal International S.C.A. (Reporting)
Invus Advisors, L.L.C. (Reporting)
Invus Public Equities Advisors, LLC (Reporting)
Invus Public Equities, L.P. (Reporting)
Invus, L.P. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Stichting Administratiekantoor Westend (Reporting)
Westend S.A. (Reporting)
Wittouck Amaury (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
3:31 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
6:26 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
3:31 PM
Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:32 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:33 PM
Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:37 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13G/A
12/29/2023
4:27 PM
Lexicon Pharmaceuticals (Filer)
Form 424B5
12/29/2023
4:29 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
"Doomsday indicator” flashing for the first time since the Great Depression... (Ad)

It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...

Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>
11/17/2023
3:55 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
4:31 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
3:16 PM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
6:22 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
3:01 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:06 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
3:06 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
4:05 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:LXRX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners